The latest prostate cancer news
More targeted, less toxic: The golden future of cancer treatment
Researchers have engineered gold-based molecules that target cancer cells and leave healthy cells unharmed, in…
Browsing: Prostate Cancer
Is prostate MRI, with or without MRI-targeted biopsy, better than systematic biopsy for detecting prostate cancer in men?
By Monique Biryiana In 2018, prostate cancer was the second most common cancer in men,…
#ANZUP19 Highlights from Brisbane
While we were set a very high benchmark on the back of last year’s ASM,…
Risks of novel oral prostate cancer therapies and pre-existing conditions
A new large population-based study shows that novel oral androgen signalling inhibitor therapies are associated…
ASCO 2019: The eight biggest stories on anticancer agents
Here is ecancer’s speedy recap on the presentations from the 2019 American Society of Clinical…
Adjuvant radiotherapy may be beneficial in treating locally advanced prostate cancer
Some 5,400 men are diagnosed with prostate cancer in Finland every year. Although in most…
FDA approves darolutamide for non-metastatic castration-resistant prostate cancer
The Food and Drug Administration (FDA) approved darolutamide for non-metastatic castration-resistant prostate cancer. Approval of…
Proton therapy for prostate cancer: does the evidence support the hype?
Stephen McMahon, Queen’s University Belfast High energy proton beam therapy, an advanced form of radiotherapy,…
Infrared chemical imaging technology promises new precision cancer diagnosis
More than 174,000 men will be diagnosed with prostate cancer this year, according to the…
Prostate cancer urine test shows who needs treatment and when
Researchers at the University of East Anglia and the Norfolk and Norwich University Hospital have…